Logo image of BTSG

BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD

20.48  -0.05 (-0.24%)

After market: 20.09 -0.39 (-1.9%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BTSG. BTSG was compared to 103 industry peers in the Health Care Providers & Services industry. While BTSG is still in line with the averages on profitability rating, there are concerns on its financial health. BTSG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year BTSG was profitable.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of 0.98%, BTSG perfoms like the industry average, outperforming 51.46% of the companies in the same industry.
BTSG has a Return On Equity (3.39%) which is comparable to the rest of the industry.
BTSG has a Return On Invested Capital (4.48%) which is in line with its industry peers.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.72%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

With a Profit Margin value of 0.49%, BTSG perfoms like the industry average, outperforming 51.46% of the companies in the same industry.
BTSG has a Operating Margin of 2.15%. This is comparable to the rest of the industry: BTSG outperforms 49.51% of its industry peers.
In the last couple of years the Operating Margin of BTSG has grown nicely.
BTSG has a worse Gross Margin (13.46%) than 69.90% of its industry peers.
In the last couple of years the Gross Margin of BTSG has declined.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
The number of shares outstanding for BTSG has been increased compared to 1 year ago.
The number of shares outstanding for BTSG has been increased compared to 5 years ago.
BTSG has a better debt/assets ratio than last year.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.82 indicates that BTSG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.82, BTSG is doing good in the industry, outperforming 61.16% of the companies in the same industry.
The Debt to FCF ratio of BTSG is 19.98, which is on the high side as it means it would take BTSG, 19.98 years of fcf income to pay off all of its debts.
BTSG has a Debt to FCF ratio (19.98) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSG has dependencies on debt financing.
With a Debt to Equity ratio value of 1.48, BTSG is not doing good in the industry: 70.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 2.82
ROIC/WACC0.48
WACC9.26%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BTSG has a Current Ratio of 1.73. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BTSG (1.73) is better than 63.11% of its industry peers.
A Quick Ratio of 1.37 indicates that BTSG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.37, BTSG perfoms like the industry average, outperforming 51.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.31% over the past year.
Looking at the last year, BTSG shows a small growth in Revenue. The Revenue has grown by 1.45% in the last year.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%

3.2 Future

BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.97% yearly.
BTSG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue Next Year9.95%
Revenue Next 2Y11.22%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BTSG is valuated quite expensively with a Price/Earnings ratio of 33.03.
The rest of the industry has a similar Price/Earnings ratio as BTSG.
BTSG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
BTSG is valuated rather expensively with a Price/Forward Earnings ratio of 19.18.
The rest of the industry has a similar Price/Forward Earnings ratio as BTSG.
BTSG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.03
Fwd PE 19.18
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BTSG's Enterprise Value to EBITDA ratio is in line with the industry average.
BTSG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.33
EV/EBITDA 13.69
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 31.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.48%

More info and screens

0

5. Dividend

5.1 Amount

BTSG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (7/28/2025, 8:11:43 PM)

After market: 20.09 -0.39 (-1.9%)

20.48

-0.05 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-01 2025-08-01/bmo
Inst Owners53.2%
Inst Owner Change0.28%
Ins Owners2.93%
Ins Owner Change17.01%
Market Cap3.61B
Analysts84.21
Price Target28.67 (39.99%)
Short Float %17.58%
Short Ratio5.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.71%
PT rev (3m)13.87%
EPS NQ rev (1m)3.25%
EPS NQ rev (3m)34.23%
EPS NY rev (1m)1.38%
EPS NY rev (3m)47.27%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)2.97%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)3.26%
Valuation
Industry RankSector Rank
PE 33.03
Fwd PE 19.18
P/S 0.31
P/FCF 28.33
P/OCF 17.69
P/B 2.14
P/tB N/A
EV/EBITDA 13.69
EPS(TTM)0.62
EY3.03%
EPS(NY)1.07
Fwd EY5.21%
FCF(TTM)0.72
FCFY3.53%
OCF(TTM)1.16
OCFY5.65%
SpS65.58
BVpS9.57
TBVpS-7.09
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 2.82
F-Score6
WACC9.26%
ROIC/WACC0.48
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.95%
Revenue Next 2Y11.22%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%